Journals / Kadın Doğum Dergisi / 2004 / Cilt: 3 - Sayı: 1

Preoperative serum CA 125 and CA 19-9 levels in patients who diagnosed uterine myoma during pathological evaluation

Patolojik incelemede myoma uteri saptanan hastalarda preoperatif serum CA 125 ve CA 19-9 düzeyleri

Pages
368–370
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mean preoperative hemoglobin levels in women who diagnosed myoma uteri were detected significantly lower than control group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of us in this retrospective study is to detect preoperative serum carbohydrate antigen 125 (CA 125) and CA 19-9 levels in women who were operated for uterine myoma and were detected having uterine myoma in the pathological evaluation, and compare with serum levels of normal women.Material and Method: Thirty-nine patients who were operated in Afyon Kocatepe University Faculty of Medicine Department of Gynecology and Obstetric for uterine myoma and detected having uterine myoma in the pathological examination between 2002 and 2004 were enrolled.
📊
Key Findings & Data:Preoperative serum CA 125 and CA 19-9 levels were measured and results were compared with serum levels of 30 normal women who have not uterine myoma or any pathology which can be increased serum CA 125 and CA 19-9 levels such as endometriosis, ovarian cyst, malignancy etc.Results: Mean preoperative serum CA 125 levels in patients with uterine myoma in definitive pathological examination were detected significantly higher than in control group (p0.05).
💡
Conclusion & Impact:Mean preoperative hemoglobin levels in women who diagnosed myoma uteri were detected significantly lower than control group (p
🔬Design:Research Article
📍Scope:2002 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of us in this retrospective study is to detect preoperative serum carbohydrate antigen 125 (CA 125) and CA 19-9 levels in women who were operated for uterine myoma and were detected having uterine myoma in the pathological evaluation, and compare with serum levels of normal women.Material and Method: Thirty-nine patients who were operated in Afyon Kocatepe University Faculty of Medicine Department of Gynecology and Obstetric for uterine myoma and detected having uterine myoma in the pathological examination between 2002 and 2004 were enrolled. Preoperative serum CA 125 and CA 19-9 levels were measured and results were compared with serum levels of 30 normal women who have not uterine myoma or any pathology which can be increased serum CA 125 and CA 19-9 levels such as endometriosis, ovarian cyst, malignancy etc.Results: Mean preoperative serum CA 125 levels in patients with uterine myoma in definitive pathological examination were detected significantly higher than in control group (p0.05). Mean preoperative hemoglobin levels in women who diagnosed myoma uteri were detected significantly lower than control group (p

Özet

Amaç: Bu retrospektif çalışmada amacımız myoma uteri nedeni ile opere edilen, patolojik incelemelerinde myoma uteri saptanan hastaların preoperatif serum Karbonhidrat Antijen 125 (CA 125) ve CA 19-9 seviyelerinin saptanıp, normal kadınların serum değerleri ile karşılaştırılmasıdır. Materyal ve Metod: Afyon Kocatepe Üniversitesi Kadın Hastalıkları ve Doğum Kliniğinde 2002-2004 yılları arasında myoma uteri tanısı nedeni ile opere edilen ve patolojik incelemesinde myoma uteri saptanan 39 hasta çalışmaya dahil edilmiştir. Preoperatif serum CA 125 ve CA 19-9 seviyeleri saptanmış ve sonuçlar myoma uteri saptanmayan ya da endometriozis, over kisti veya malignansi gibi serum CA 125 ve CA 19-9 seviyelerini arttırabilecek bir patoloji saptanmayan 30 normal kadının serum değerleri ile karşılaştırılmıştır.Bulgular: Kesin patolojik incelemelerinde myoma uteri saptanan hastalarda ortalama preoperatif serum CA 125 değerleri kontrol grubundan anlamlı olarak yüksek bulunmuştur (p0.05). Myoma uteri saptanan hastalarda ortalama preoperatif hemoglobin düzeyleri kontrol grubundan anlamlı oranda düşük olarak bulunmuştur(p

🔖

Cite This Article

YILMAZER, M., SERTESER, M., TOKYOL, Ç., FENKCİ, V., CEVRİOĞLU, S., ÇOKSÜER, H. (2022). Preoperative serum CA 125 and CA 19-9 levels in patients who diagnosed uterine myoma during pathological evaluation. Kadın Doğum Dergisi, Cilt: 3 - Sayı: 1, 368–370. https://ajindex.com/articles/569091

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Bast RC, Fecney M, Lazarus H, Nadlcr LM. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981;68:1331-7. 2-Boyer CM, Knapp RC, Bast Jr RC. Biology and immunology. In: Berek JS, Hacker NF (eds.). Practical Gynecologic Oncology, 2nd edn. Baltimore: Williams and Wilkins; 1994; 89-90. 3-Niloff JM, Klug TL, Schaetzl E, Zurawski WR, Knapp RC, Bast RC. Elevation of serum CA 125 in carcinomas of the fallopian tube, endometrium and endocervix. Am J Obstet Gynecol 1984; 148: İ057-8. 4-Bast RC, Klug TL, St John E, Jenîson E, Niloff JM, Lazarus H et al. A radioimmunoassay using a monoclonal antibody to monitor the courseofepithelial ovarian cancer. N Engl J Med 1983;309:883-7, 5-Koprowski H, Steplcwski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 1979; 5:957-72. 6-Ohshio G, Yamaki K, Imamura T, et al. Distribution of the carbohydrate antigens, DU-PAN-2 and CA 19-9, in tumors of the lung. Tumori 1995;81:67-73. 7-Del Villano BC, Brennam S, Brock P, et al. Radioimmunometric assay fora monoclonal antibody-defined tumor marker, CA 19-9,ClinChem 1983; 29:549-52. 8-Ye C, Ito K, Kamalsu Y, Takagi H. Extremely high levels of CA 19-9 and CA 125 antigen in benign mucinous ovarian cystadenoma. Gynecol Oncol 1994; 52:267-271. 9-Yilmazer M, Sonmezer M, Gungor M, Fenkci V,CevriogluS. Unusually elevated serum CA 125 and CA 19-9 levels as a resultof unruptured bilateral endometrioma. AustN Z J Obstet Gynaecol, 2003;43:329-330. 10-Nagata H, Takahashi K, Yamanc Y, Yoshino K, ShibukawaT, Kitao M. Abnormally high values ofCA 125 and CA 19-9 in women with benign tumors. Gynecol Obstet Invest 1989;28:165-168. 11-Harada T, Kubota T, Aso T. Usefulness of CA i 9-9 versus CA 125 for the diagnosis of'endometriosis. Fertil Steril 2002;78:733-9. 12-Imai A, Horibe S, Takagi H, Tamaya T. Drastic elevation of serum CA 125, CA 72-4 and CA 19-9 levels during menses in a patient with probable endometriosis, Eur J Obstet Gynecol Biol 1998;78:79-81. 13-Takemori M, Sugimura K. Ovarian chocolate cyst with markedly elevated serum CA 19-9 level: a case report. Eur J Obstet Gynecol Biol 1991;42:241-4. 14-Habcral A, Gükçü M. Corpus uterinin benign hastalıkları. Çiçek MN, Akytlrck C, Çelik Ç, Haberal A (editörler). Kadın Hastalıkları ve Doğum Bilgisi. Güneş Kitabevi, 2004
  2. Ankara, Sayfa: 602-613. 15-Vasiliev SA, Schacrth J, Campeau J. Serum CA 125 levels in preoperative evaluation of pelvic masses.